Progress in Neuropsychopharmacology & Biological Psychiatry Characterisation of methylphenidate-induced excitation in midbrain dopamine neurons, an electrophysiological study in the rat brain
暂无分享,去创建一个
A. Omoloye | M. Miceli | B. Gronier | Mathieu Di | Miceli France | PhD Mathieu Di Miceli | PhD Adesina Omoloye | PhD Benjamin Gronier
[1] C. Jiménez-Rivera,et al. Alpha-1 Adrenergic Receptors Modulate Glutamate and GABA Neurotransmission onto Ventral Tegmental Dopamine Neurons during Cocaine Sensitization , 2020, International journal of molecular sciences.
[2] Elyssa B. Margolis,et al. Relative contributions and mapping of ventral tegmental area dopamine and GABA neurons by projection target in the rat , 2018, The Journal of comparative neurology.
[3] A. Omoloye,et al. Chronic methylphenidate treatment during adolescence has long-term effects on monoaminergic function , 2018, Journal of psychopharmacology.
[4] T. Banaschewski,et al. Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder. , 2018, Journal of child and adolescent psychopharmacology.
[5] I. S. Esin,et al. Myasthenia Gravis Attack after Oral Risperidone Treatment: A Case Report. , 2018, The Eurasian journal of medicine.
[6] W. Shi,et al. Methylphenidate significantly alters the functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area , 2018, Neuropharmacology.
[7] N. Dafny,et al. Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats. , 2017, Journal of neurophysiology.
[8] Daniel J. Chandler,et al. Noradrenergic Modulation of Cognition in Health and Disease , 2017, Neural plasticity.
[9] N. Dafny,et al. Methylphenidate modulates dorsal raphe neuronal activity: Behavioral and neuronal recordings from adolescent rats , 2017, Brain Research Bulletin.
[10] A. Grace. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression , 2016, Nature Reviews Neuroscience.
[11] J. Millichap,et al. Dystonia with MPH/Risperidone Combined Therapy for ADHD , 2016, Pediatric neurology briefs.
[12] B. Lambolez,et al. A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine , 2015, Scientific Reports.
[13] M. Miceli,et al. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors , 2015, Psychopharmacology.
[14] C. Paladini,et al. Generating bursts (and pauses) in the dopamine midbrain neurons , 2014, Neuroscience.
[15] Boris S. Gutkin,et al. Mechanisms for multiple activity modes of VTA dopamine neurons , 2014, bioRxiv.
[16] J. Azorin,et al. Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report , 2014, Neuropsychiatric disease and treatment.
[17] A. Grace,et al. The Infralimbic Cortex Bidirectionally Modulates Mesolimbic Dopamine Neuron Activity via Distinct Neural Pathways , 2013, The Journal of Neuroscience.
[18] L. Rojas,et al. Alpha-1 adrenoreceptors modulate GABA release onto ventral tegmental area dopamine neurons , 2015, Neuropharmacology.
[19] H. Pontén,et al. The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex , 2013, Journal of Neural Transmission.
[20] B. Waterhouse,et al. Distinct Age-Dependent Effects of Methylphenidate on Developing and Adult Prefrontal Neurons , 2012, Biological Psychiatry.
[21] A. Grace,et al. Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons , 2012, Trends in Neurosciences.
[22] N. Dafny,et al. Acute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving rats. , 2012, European journal of pharmacology.
[23] P. Piazza,et al. Coupled intracerebral microdialysis and electrophysiology for the assessment of dopamine neuron function in vivo. , 2012, Journal of pharmacological and toxicological methods.
[24] Natalia del Campo,et al. The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder , 2011, Biological Psychiatry.
[25] A. Ettenberg,et al. Effects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in rats , 2011, Psychopharmacology.
[26] D. Lodge. The Medial Prefrontal and Orbitofrontal Cortices Differentially Regulate Dopamine System Function , 2011, Neuropsychopharmacology.
[27] B. Gronier. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: Involvement of dopamine D1 and alpha 2 adrenergic receptors , 2011, European Neuropsychopharmacology.
[28] Rune W. Berg,et al. Influence of Phasic and Tonic Dopamine Release on Receptor Activation , 2010, The Journal of Neuroscience.
[29] J. Yanofski. The dopamine dilemma: using stimulants and antipsychotics concurrently. , 2010, Psychiatry (Edgmont (Pa. : Township)).
[30] D. Pemberton,et al. Alternative method of oral dosing for rats. , 2010, Journal of the American Association for Laboratory Animal Science : JAALAS.
[31] P. Blier,et al. Relevance of Norepinephrine–Dopamine Interactions in the Treatment of Major Depressive Disorder , 2010, CNS neuroscience & therapeutics.
[32] T. Zetterström,et al. Age-dependent effects of methylphenidate in the prefrontal cortex: evidence from electrophysiological and Arc gene expression measurements , 2010, Journal of psychopharmacology.
[33] A. Swann,et al. Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate , 2009, Brain Research.
[34] Anthony A Grace,et al. Entorhinal cortex inhibits medial prefrontal cortex and modulates the activity states of electrophysiologically characterized pyramidal neurons in vivo. , 2009, Cerebral cortex.
[35] J. Pruessner,et al. Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate , 2008, Current neuropharmacology.
[36] E. Szabadi,et al. Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part I: Principles of Functional Organisation , 2008, Current neuropharmacology.
[37] E. Szabadi,et al. Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part II: Physiological and Pharmacological Manipulations and Pathological Alterations of Locus Coeruleus Activity in Humans , 2008, Current neuropharmacology.
[38] J. Markowitz,et al. Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? , 2008, Journal of clinical psychopharmacology.
[39] T. Wilens. Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder , 2008, Journal of clinical psychopharmacology.
[40] A. Swann,et al. Methylphenidate sensitization is prevented by prefrontal cortex lesion , 2008, Brain Research Bulletin.
[41] C. Hollis,et al. Acute dyskinesia on starting methylphenidate after risperidone withdrawal. , 2007, Pediatric neurology.
[42] M. Kurachi,et al. Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex , 2007, Synapse.
[43] S. Sesack,et al. Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources , 2007, Neuroscience.
[44] D. S. Zahm,et al. Glutamatergic Afferents of the Ventral Tegmental Area in the Rat , 2007, The Journal of Neuroscience.
[45] Wei-Xing Shi,et al. Behavioral/systems/cognitive Functional Coupling between the Prefrontal Cortex and Dopamine Neurons in the Ventral Tegmental Area , 2022 .
[46] A. Swann,et al. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization , 2007, Brain Research.
[47] E. Hess,et al. D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD , 2007, Neurobiology of Disease.
[48] F. Marshall,et al. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain , 2007, Neuropharmacology.
[49] O. Sabuncuoğlu. Risperidone-to-methylphenidate switch reaction in children: three cases , 2006, Journal of psychopharmacology.
[50] Carmen Moreno,et al. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. , 2006, Archives of general psychiatry.
[51] Charles J. Wilson,et al. Transient high-frequency firing in a coupled-oscillator model of the mesencephalic dopaminergic neuron. , 2006, Journal of neurophysiology.
[52] B. Goñi-Allo,et al. Ibotenic acid lesions of the medial prefrontal cortex block the development and expression of 3,4-methylenedioxymethamphetamine-induced behavioral sensitization in rats , 2005, Behavioural Brain Research.
[53] G. Bernardi,et al. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain , 2005, Biological Psychiatry.
[54] W. Shi,et al. Psychostimulants Induce Low-Frequency Oscillations in the Firing Activity of Dopamine Neurons , 2004, Neuropsychopharmacology.
[55] R. Shen,et al. Methylphenidate Restores Ventral Tegmental Area Dopamine Neuron Activity in Prenatal Ethanol-Exposed Rats by Augmenting Dopamine Neurotransmission , 2004, Journal of Pharmacology and Experimental Therapeutics.
[56] J. Bolam,et al. Uniform Inhibition of Dopamine Neurons in the Ventral Tegmental Area by Aversive Stimuli , 2004, Science.
[57] D. Hanck,et al. Molecular Action of Lidocaine on the Voltage Sensors of Sodium Channels , 2003, The Journal of general physiology.
[58] A. Phillips,et al. Modulation by Central and Basolateral Amygdalar Nuclei of Dopaminergic Correlates of Feeding to Satiety in the Rat Nucleus Accumbens and Medial Prefrontal Cortex , 2002, The Journal of Neuroscience.
[59] Antonio Pisani,et al. Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors , 2002, Neuropsychopharmacology.
[60] Harold Alan Pincus,et al. National trends in the outpatient treatment of depression. , 2002, JAMA.
[61] M. Jackson,et al. Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens , 2001, Journal of neurochemistry.
[62] M. Millan,et al. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. , 2001, The Journal of pharmacology and experimental therapeutics.
[63] T. Svensson,et al. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. , 2001, The Journal of pharmacology and experimental therapeutics.
[64] S. Sesack,et al. Projections from the Rat Prefrontal Cortex to the Ventral Tegmental Area: Target Specificity in the Synaptic Associations with Mesoaccumbens and Mesocortical Neurons , 2000, The Journal of Neuroscience.
[65] Susan G. Amara,et al. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor , 2000, Biological Psychiatry.
[66] B. Bunney,et al. Dual Effects of d-Amphetamine on Dopamine Neurons Mediated by Dopamine and Nondopamine Receptors , 2000, The Journal of Neuroscience.
[67] S. Floresco,et al. Reversible lesions of the rhinal cortex produce delayed non‐matching‐to‐sample deficits in rats , 2000, Neuroreport.
[68] B. Bunney,et al. Endogenous DA‐mediated feedback inhibition of DA neurons: Involvement of both D1‐ and D2‐like receptors , 2000, Synapse.
[69] Y Li,et al. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations , 1999, Synapse.
[70] S. Cannon,et al. The Position of the Fast-Inactivation Gate during Lidocaine Block of Voltage-gated Na+ Channels , 1999, The Journal of general physiology.
[71] P. Overton,et al. Burst firing in midbrain dopaminergic neurons , 1997, Brain Research Reviews.
[72] P. Kalivas,et al. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine , 1997, Neuroscience.
[73] Marc A Sommer,et al. Effective spread and timecourse of neural inactivation caused by lidocaine injection in monkey cerebral cortex , 1997, Journal of Neuroscience Methods.
[74] J. Tepper,et al. Functional Roles of Dopamine D2 and D3Autoreceptors on Nigrostriatal Neurons Analyzed by Antisense KnockdownIn Vivo , 1997, The Journal of Neuroscience.
[75] S. Sara,et al. Inhibitory influence of frontal cortex on locus coeruleus neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[76] F. Gonon,et al. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo , 1993, Neuroscience Letters.
[77] D. Clark,et al. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons. , 1993, The Journal of pharmacology and experimental therapeutics.
[78] T. Svensson,et al. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. , 1993, European journal of pharmacology.
[79] G Chouvet,et al. Tonic Activation of NMDA Receptors Causes Spontaneous Burst Discharge of Rat Midbrain Dopamine Neurons In Vivo , 1993, The European journal of neuroscience.
[80] L. Chiodo,et al. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons , 1992, Brain Research.
[81] R. Roth,et al. Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[82] John H. Martin. Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat , 1991, Neuroscience Letters.
[83] D. Weinberger,et al. Ibotenic acid lesions of the medial prefrontal cortex potentiate FG-7142-induced attenuation of exploratory activity in the rat , 1990, Pharmacology Biochemistry and Behavior.
[84] T. Svensson,et al. Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. , 1989, Acta physiologica Scandinavica.
[85] F. Gonon. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry , 1988, Neuroscience.
[86] P. Johansen,et al. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[87] Menek Goldstein,et al. Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area , 1986, Brain Research.
[88] J. Yeh,et al. Na channel activation gate modulates slow recovery from use-dependent block by local anesthetics in squid giant axons. , 1985, Biophysical journal.
[89] A. Grace,et al. The control of firing pattern in nigral dopamine neurons: burst firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[90] A. Grace,et al. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization , 1983, Neuroscience.
[91] L. Swanson,et al. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat , 1982, Brain Research Bulletin.
[92] W. Nauta,et al. Efferent connections of the substantia nigra and ventral tegmental area in the rat , 1979, Brain Research.
[93] Barbara E. Jones,et al. Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study , 1977, Brain Research.
[94] K. Courtney. Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. , 1975, The Journal of pharmacology and experimental therapeutics.
[95] E. M. Miller. Dopamine and Glutamate Dysfunction in a Rodent Model of Attention-Deficit/Hyperactivity Disorder: Implications for Future Neuropharmacology , 2014 .
[96] N. Dafny,et al. Acute and chronic dose–response effect of methylphenidate on ventral tegmental area neurons correlated with animal behavior , 2013, Journal of Neural Transmission.
[97] P. Blier,et al. Electrophysiological Effects of Repeated Administration of Agomelatine on the Dopamine, Norepinephrine, and Serotonin Systems in the Rat Brain , 2013, Neuropsychopharmacology.
[98] P. Overton,et al. Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex , 2005, Journal of Neural Transmission.
[99] H. Simon,et al. Anatomical relationships between the ventral mesencephalic tegmentum — A 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques , 2005, Journal of Neural Transmission.
[100] G. Aston-Jones,et al. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat , 2005, Journal of Neural Transmission / General Section JNT.
[101] Davide Viggiano,et al. Dysfunctions in Dopamine Systems and ADHD: Evidence From Animals and Modeling , 2004, Neural plasticity.
[102] W. Catterall. Molecular mechanisms of gating and drug block of sodium channels. , 2002, Novartis Foundation symposium.
[103] J. Fellous,et al. A Roles of Dopamine , 2002 .
[104] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .